Mirjam Andreasson

Mirjam Andreasson (Ochsner) is an experienced professional in the fields of innovation and clinical affairs, currently serving as Director of Innovation & Clinical Affairs at HemoCue AB since January 2013. A progressive career at HemoCue AB includes roles such as Senior Manager for Technology & Innovation and Technical Project Manager, among others. Prior to HemoCue, Mirjam was a Research Engineer at A*STAR, focusing on the development of artificial cell membrane technology, and completed a PhD at ETH Zurich, concentrating on single cell microarray platforms. Additional internships at Clariant, Edwards Lifesciences, and Seoul National University contributed to a well-rounded expertise in materials engineering and bionanotechnology. Education credentials include degrees from Harvard Business School Online, ETH Zurich, and Chalmers University of Technology, complemented by a strong foundation in Latin and Italian from Stiftsschule Einsiedeln.